Long-term outcomes in patients with chronic hepatitis C in the current era of direct-acting antiviral agents-Reference-Cited by-同舟云学术

Long-term outcomes in patients with chronic hepatitis C in the current era of direct-acting antiviral agents

Published:2019-04-30 Issue:5 Volume:17 Page:311-325
ISSN:1478-7210
Container-title:Expert Review of Anti-infective Therapy
language:en
Short-container-title:Expert Review of Anti-infective Therapy

Author:

Wei Lai¹²,Huang Yi-Hsiang³

Affiliation:

1. Center for Hepatology Pancrease Disease, Beijing Tsinghua Changgung Hospital, Tsinghua University, Beijing

2. Peking University Hepatology Institute, Beijing Key Laboratory for Hepatitis C and Immunotherapy for Liver Disease, Peking University People’s Hospital, Beijing

3. Division of Gastroenterology and Hepatology, Taipei Veterans General Hospital, Taipei

Funder

Bristol-Myers Squibb

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Microbiology (medical),Microbiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14787210.2019.1588112

Reference68 articles.

1. Treatment of hepatitis C: momentum still needed

2. Are we nearing the end in the fight against hepatitis C?

3. American Gastroenterological Association Institute Clinical Practice Update—Expert Review: Care of Patients Who Have Achieved a Sustained Virologic Response After Antiviral Therapy for Chronic Hepatitis C Infection

4. Risk of Late Relapse or Reinfection With Hepatitis C Virus After Achieving a Sustained Virological Response: A Systematic Review and Meta-analysis

5. Earlier Sustained Virologic Response End Points for Regulatory Approval and Dose Selection of Hepatitis C Therapies

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The possible pathogenesis of liver fibrosis: therapeutic potential of natural polyphenols;Pharmacological Reports;2024-08-20

2. Treatment of Chronic Hepatitis C in Older Adults;Korean Journal of Clinical Geriatrics;2023-12-30

3. Dynamics of liver stiffness predicts complications in patients with HCV related cirrhosis treated with direct-acting antivirals;Digestive and Liver Disease;2023-11

4. Investigating rates and risk factors for hepatitis C virus reinfection in people receiving antiviral treatment in England;Journal of Viral Hepatitis;2023-04-13

5. Peptidomimetics: An Overview of Recent Medicinal Chemistry Efforts toward the Discovery of Novel Small Molecule Inhibitors;Journal of Medicinal Chemistry;2022-05-23